Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy

Respiratory syncytial virus (RSV) infection is the most frequent cause of hospitalization in infants and young children worldwide. Although mucosal RSV vaccines can reduce RSV disease burden, little is known about mucosal immune response capabilities in children. Neonatal or adult mice were infected...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Sci Rep
Egile Nagusiak: Hijano, Diego R., Siefker, David T., Shrestha, Bishwas, Jaligama, Sridhar, Vu, Luan D., Tillman, Heather, Finkelstein, David, Saravia, Jordy, You, Dahui, Cormier, Stephania A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6056463/
https://ncbi.nlm.nih.gov/pubmed/30038294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-29456-w
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak